Similar articles for PMID: 15736475

Year	Number of Results
1981	2
1982	1
1983	2
1984	3
1985	3
1986	4
1988	2
1989	3
1990	2
1991	9
1992	4
1993	4
1994	2
1995	6
1996	7
1997	10
1998	6
1999	10
2000	11
2001	11
2002	8
2003	12
2004	9
2005	8
2006	14
2007	13
2008	7
2009	2
2010	4
2011	3
2012	4
2024	0

1

A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer.

Kouroussis C, Kalbakis K, Androulakis N, Agelaki S, Vamvakas L, Malas K, Souglakos J, Vardakis N, Georgoulias V. Kouroussis C, et al. Anticancer Res. 2004 Nov-Dec;24(6):4217-21. Anticancer Res. 2004. PMID: 15736475 Free article. Clinical Trial.

2

Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.

Pieńkowski T, Jagiello-Gruszfeld A. Pieńkowski T, et al. Int J Clin Pharmacol Res. 2001;21(3-4):111-7. Int J Clin Pharmacol Res. 2001. PMID: 12067140

3

Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.

Kalbakis K, Kouroussis C, Kakolyris S, Mavroudis D, Souglakos J, Agelaki S, Vamvakas L, Christodoulakis M, Stylianou K, Georgoulias V. Kalbakis K, et al. Br J Cancer. 2001 Sep 14;85(6):798-802. doi: 10.1054/bjoc.2001.2001. Br J Cancer. 2001. PMID: 11556827 Free PMC article. Clinical Trial.

4

Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).

Gebbia V, Caruso M, Borsellino N, Ajello R, Tirrito ML, Chiarenza M, Valenza R, Verderame F, Varvara F, Marrazzo A, Bajardi E, Ferrao F, Bordonaro R, Tralongo P. Gebbia V, et al. Anticancer Res. 2006 Jul-Aug;26(4B):3143-50. Anticancer Res. 2006. PMID: 16886648 Free article.

5

A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors.

Souglakos J, Kakolyris S, Vardakis N, Androulakis N, Mavroudis D, Vamvakas L, Kouroussis C, Agelaki S, Saridaki Z, Georgoulias V. Souglakos J, et al. Cancer Invest. 2005;23(6):505-10. doi: 10.1080/07357900500202713. Cancer Invest. 2005. PMID: 16203658 Clinical Trial.

6

Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.

Delva R, Pienkowski T, Tubiana N, Vanhoefer U, Longerey B, Douville I. Delva R, et al. Cancer Chemother Pharmacol. 2007 May;59(6):703-9. doi: 10.1007/s00280-006-0324-4. Epub 2006 Sep 22. Cancer Chemother Pharmacol. 2007. PMID: 17021821 Clinical Trial.

7

Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.

Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K. Yamada Y, et al. Jpn J Clin Oncol. 2006 Apr;36(4):218-23. doi: 10.1093/jjco/hyl020. Jpn J Clin Oncol. 2006. PMID: 16684860 Clinical Trial.

8

Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studies.

Passardi A, Maltoni R, Milandri C, Cecconetto L, Massa I, Zoli W, Tesei A, Fabbri F, Nanni O, Amadori D. Passardi A, et al. Oncology. 2007;72(1-2):118-24. doi: 10.1159/000111130. Epub 2007 Nov 15. Oncology. 2007. PMID: 18004083 Clinical Trial.

9

A phase I dose-escalating study of docetaxel plus folinic acid and 5-fluorouracil in anthracycline-pretreated patients with metastatic breast cancer.

Slee PH, Rodenburg CJ, Nortier JW, van Bochove A. Slee PH, et al. Neth J Med. 2004 Oct;62(9):314-9. Neth J Med. 2004. PMID: 15635815 Free article. Clinical Trial.

10

Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.

Gebbia V, Mauceri G, Testa A, Tirrito M, Varvara F, Cucchiara A, Borsellino N, Girlando A, Ferrara M, Caruso F. Gebbia V, et al. Anticancer Res. 1999 May-Jun;19(3B):2289-92. Anticancer Res. 1999. PMID: 10472346 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

178 results

Results by year